Here, we identified a homozygous missense variant (c.2312T > C:p.Leu771Ser) in BRCA1 as the likely cause of breast cancer among selected patients, reinforcing the need to integrate genetic screening into clinical care for high-risk populations. Here, BRCA1 is linked to breast cancer.